NDC 71335-0361

Celecoxib

Celecoxib

Celecoxib is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Celecoxib.

Product ID71335-0361_b9555f14-a37f-42bb-ad52-95f9192c09c0
NDC71335-0361
Product TypeHuman Prescription Drug
Proprietary NameCelecoxib
Generic NameCelecoxib
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2015-06-03
Marketing CategoryANDA / ANDA
Application NumberANDA204197
Labeler NameBryant Ranch Prepack
Substance NameCELECOXIB
Active Ingredient Strength200 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 71335-0361-9

56 CAPSULE in 1 BOTTLE (71335-0361-9)
Marketing Start Date2015-06-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0361-9 [71335036109]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

NDC 71335-0361-7 [71335036107]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

NDC 71335-0361-4 [71335036104]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

NDC 71335-0361-0 [71335036100]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

NDC 71335-0361-2 [71335036102]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

NDC 71335-0361-5 [71335036105]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

NDC 71335-0361-6 [71335036106]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

NDC 71335-0361-8 [71335036108]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

NDC 71335-0361-3 [71335036103]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

NDC 71335-0361-1 [71335036101]

Celecoxib CAPSULE
Marketing CategoryANDA
Application NumberANDA204197
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-03-31
Marketing End Date2019-03-31

Drug Details

Active Ingredients

IngredientStrength
CELECOXIB200 mg/1

OpenFDA Data

SPL SET ID:d94849a7-1831-4319-982c-c6b20dc42038
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 205322
  • 205323
    • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
    • NUI Code
  • N0000000160
  • N0000175722
  • N0000175721

    • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]

    NDC Crossover Matching brand name "Celecoxib" or generic name "Celecoxib"

    NDCBrand NameGeneric Name
    0093-7165CelecoxibCelecoxib
    0093-7166CelecoxibCelecoxib
    0093-7170CelecoxibCelecoxib
    0093-7306CelecoxibCelecoxib
    68071-2164CelecoxibCelecoxib
    68071-2169CelecoxibCelecoxib
    68071-4252CelecoxibCelecoxib
    68071-4392celecoxibcelecoxib
    68071-4642CELECOXIBCELECOXIB
    68071-4476CelecoxibCelecoxib
    68084-976CelecoxibCelecoxib
    68084-969CelecoxibCelecoxib
    68180-395celecoxibcelecoxib
    68180-396celecoxibcelecoxib
    68180-398celecoxibcelecoxib
    68180-397celecoxibcelecoxib
    68788-6393CELECOXIBCELECOXIB
    68788-6463CelecoxibCelecoxib
    68788-6941CelecoxibCelecoxib
    68788-9274CelecoxibCelecoxib
    68788-8936CelecoxibCelecoxib
    68788-7134CelecoxibCelecoxib
    68788-8924CelecoxibCelecoxib
    68788-9273CelecoxibCelecoxib
    68788-9993CelecoxibCelecoxib
    69097-421CELECOXIBCELECOXIB
    69097-420CELECOXIBCELECOXIB
    69097-422CELECOXIBCELECOXIB
    69097-423CELECOXIBCELECOXIB
    69677-154CelecoxibCelecoxib
    70518-1346celecoxibcelecoxib
    0591-3982CelecoxibCelecoxib
    70518-1650celecoxibcelecoxib
    0591-3984CelecoxibCelecoxib
    0591-3985CelecoxibCelecoxib
    0591-3983CelecoxibCelecoxib
    70882-129CelecoxibCelecoxib
    70934-026CelecoxibCelecoxib
    71205-020CelecoxibCelecoxib
    71205-027celecoxibcelecoxib
    71205-055CelecoxibCelecoxib
    71335-0361CelecoxibCelecoxib
    71335-0597CelecoxibCelecoxib
    71335-0936celecoxibcelecoxib
    71335-0868celecoxibcelecoxib
    71335-0292CelecoxibCelecoxib
    71335-0450CELECOXIBCELECOXIB
    71335-0437CelecoxibCelecoxib
    71626-302CelecoxibCelecoxib
    71626-303CelecoxibCelecoxib
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.